Publication | Closed Access

A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: A RTOG randomized study (#79-04)

Neuro-oncologyRadiation TherapyPhase I/ii StudyMedicineHypoxic CellHead And Neck CancerNeck OncologyOncologyRadiation OncologyTreatment ResistanceRadiologyHealth Sciences